FIELD: medicine.
SUBSTANCE: method involves introducing an agent containing gold nanoparticles and an iodine-containing contrast agent into a tumour. The above agent is introduced into the tumour directly that is followed by the tumour exposure to photon ionising gamma radiation 60Co. The method enables increasing a dose of photon therapy directly into the tumour tissue by 10% in a combination with reducing a radiation exposure on normal tissues.
EFFECT: invention extends the range of the methods for internal tumour therapy, e.g. pulmonary, gastrointestinal, female and male genital and lymphoid tumours.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING EHRLICH ADENOCARCINOMA BY MEANS OF RADIATION THERAPY | 2021 |
|
RU2781902C1 |
| METHOD OF PROTON THERAPY FOR SOLID EHRLICH CARCINOMA | 2023 |
|
RU2808984C1 |
| METHOD FOR APPLYING PHOTON-CAPTURING TUMOR THERAPY | 2004 |
|
RU2270045C1 |
| METHOD FOR PHOTODYNAMIC THERAPY OF LEFT TUMORS OF MICE EHRLICH CARCINOMA WITH CHLORINE SERIES PHOTO-SENSITIZER | 2022 |
|
RU2788766C2 |
| METHOD FOR ERRLICH ADENOCARCINOMA TREATMENT | 2022 |
|
RU2794457C1 |
| METHODS FOR COMBINED THERAPY OF MALIGNANT NEOPLASMS USING IRON OXIDE NANOPARTICLES | 2023 |
|
RU2816227C1 |
| METHOD FOR PHOTO-ACTIVATED TREATMENT OF TUMOUR CELLS FOR PRODUCING CELLULAR AGENTS | 2021 |
|
RU2775382C1 |
| METHOD OF TUMOUR CELLS PROLIFERATION INHIBITION | 2006 |
|
RU2326707C1 |
| METHOD OF REDUCING TUMOR CELL VIABILITY | 2022 |
|
RU2799517C1 |
| METHOD FOR INDUCTION OF AN ABSCOPAL ANTITUMOR EFFECT IN THE EXPERIMENTAL MODEL OF EHRLICH'S CARCINOMA | 2020 |
|
RU2736120C2 |
